Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Isotopes and Radioisotopes01:28

Isotopes and Radioisotopes

In the early 1900s, English chemist Frederick Soddy realized that an element could have atoms with different masses that were chemically indistinguishable. These different types are called isotopes — atoms of the same element that differ in mass. Isotopes differ in mass because they have different numbers of neutrons but are chemically identical because they have the same number of protons. Soddy was awarded the Nobel Prize in Chemistry in 1921 for this discovery.
An isotope containing more...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Developmental status and prospect of musical electroacupuncture].

Zhongguo zhen jiu = Chinese acupuncture & moxibustion·2015
Same author

The Brainstem Oscillator for Whisking and the Case for Breathing as the Master Clock for Orofacial Motor Actions.

Cold Spring Harbor symposia on quantitative biology·2015
Same author

Utility of Tc-PEG4-E[PEG4-c(RGDfK)]2 in Posttherapy Surveillance of Patients with Reelevated Carcinoembryonic Antigen Levels.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre·2015
Same author

Characterization of the impurities and isomers in cefetamet pivoxil hydrochloride by liquid chromatography/time-of-flight mass spectrometry and ion trap mass spectrometry.

Journal of pharmaceutical and biomedical analysis·2015
Same author

(68)Ga-labeled 3PRGD2 for dual PET and Cerenkov luminescence imaging of orthotopic human glioblastoma.

Bioconjugate chemistry·2015
Same author

An exploratory study on 99mTc-RGD-BBN peptide scintimammography in the assessment of breast malignant lesions compared to 99mTc-3P4-RGD2.

PloS one·2015
Same journal

[<sup>68</sup>Ga]Ga-DOTA-TOC Synthesis by a Cassette Developer System with [<sup>68</sup>Ga]GaCl<sub>3</sub> from Cyclotron using Liquid Target: An Italian Experience.

Current radiopharmaceuticals·2025
Same journal

Evaluating the Effectiveness of Geant4 Software in Measuring the Damage Caused by Ti48 Ion Radiation on Nerve Cells, in Comparison to the Biophysical Model and Empirical Data.

Current radiopharmaceuticals·2025
Same journal

Synergistic Potential of GLP-1 Receptor Agonists and Radiotherapy in Breast Cancer Treatment: A New Therapeutic Avenue (TROD-GROG 006).

Current radiopharmaceuticals·2025
Same journal

Real-world Data on Intermediate-risk Differentiated Thyroid Cancer Biochemical Response to 3700 or 5550 MBq of [<sup>131</sup>I]Sodium Iodide.

Current radiopharmaceuticals·2025
Same journal

RNA Binding Proteins are Pivotal Regulators of Cancer Radioresistance and Potential Targets for Preventing Tumor Recurrence.

Current radiopharmaceuticals·2025
Same journal

Nuclear Nanomedicines: Utilization of Radiolabelling Strategies, Drug Formulation, Delivery, and Regulatory Aspects for Disease Management.

Current radiopharmaceuticals·2025
See all related articles

Related Experiment Video

Updated: May 26, 2026

Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases
11:03

Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases

Published on: May 29, 2017

PET tracers based on (86)Y.

Jinming Huang1, Liyang Cui, Fan Wang

  • 1Medical Isotopes Research Center, Peking University, Beijing, China.

Current Radiopharmaceuticals
|December 24, 2011
PubMed
Summary
This summary is machine-generated.

Positron emission tomography (PET) uses novel radioactive tracers. This review focuses on 86Yttrium (86Y) PET tracers, highlighting their potential for molecular imaging and cancer detection in clinical trials.

More Related Videos

Solid Phase 11C-Methylation, Purification and Formulation for the Production of PET Tracers
09:25

Solid Phase 11C-Methylation, Purification and Formulation for the Production of PET Tracers

Published on: October 24, 2019

The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies
09:29

The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies

Published on: February 12, 2015

Related Experiment Videos

Last Updated: May 26, 2026

Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases
11:03

Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases

Published on: May 29, 2017

Solid Phase 11C-Methylation, Purification and Formulation for the Production of PET Tracers
09:25

Solid Phase 11C-Methylation, Purification and Formulation for the Production of PET Tracers

Published on: October 24, 2019

The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies
09:29

The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies

Published on: February 12, 2015

Area of Science:

  • Nuclear medicine
  • Radiochemistry
  • Molecular imaging

Background:

  • Positron emission tomography (PET) is crucial for studying biological processes.
  • Traditional PET isotopes (18F, 11C, 13N, 15O) have short half-lives, limiting long-term in vivo studies.
  • Development of unconventional radionuclides (e.g., 64Cu, 68Ga, 89Zr, 86Y, 124I) offers complementary half-lives for PET tracers.

Purpose of the Study:

  • To review the physical characteristics, production, and radiochemistry of 86Yttrium (86Y).
  • To summarize current 86Y-based PET tracers for molecular imaging and cancer detection.
  • To discuss the application of 86Y PET tracers in animal studies and clinical trials.

Main Methods:

  • Review of existing literature on 86Yttrium.
  • Analysis of physical properties, production methods, and radiochemical applications of 86Y.
  • Compilation of data on 86Y-based PET tracers used in preclinical and clinical settings.

Main Results:

  • 86Yttrium offers advantageous characteristics for PET imaging.
  • 86Y-based tracers are valuable for in vivo biodistribution and dosimetry of therapeutic 90Y pharmaceuticals.
  • A range of 86Y-based PET tracers are being explored for molecular imaging and cancer detection.

Conclusions:

  • 86Yttrium is a promising radionuclide for developing advanced PET tracers.
  • 86Y PET tracers show significant potential in molecular imaging, particularly for cancer detection.
  • Further research and clinical trials involving 86Y-based tracers are warranted.